Skip to content
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
TNC FlipBook Classic items
25042025-PR_Report_Publishing_EN
By
admin
April 25, 2025
2025_04-22_PR_OBA_Market_Potential
By
admin
April 21, 2025
2025-04-22_CP_Potentiel_de_marché_OBA
By
admin
April 21, 2025
2025-04-09_Lancement_Phase_2_OBA_FR
By
admin
April 9, 2025
2025-04-09_Launch_OBA_EN
By
admin
April 9, 2025
2025-03-28_PR_Settlement_and-Delivery_Announcement_Biophytis
By
admin
March 28, 2025
2025-03-28_CP_Annonce_règlement_livraison_Biophytis
By
admin
March 28, 2025
2025-03-26_Placement_Prive_CP
By
admin
March 26, 2025
2025-03-26_Private Placement_PR
By
admin
March 26, 2025
240325_PR_ICFSR
By
admin
March 24, 2025
←
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
…
22
23
24
25
26
…
27
28
29
30
31
32
33
34
→
Go to Top
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
